Skip to main content
Clinical Trials/NCT06514365
NCT06514365
Recruiting
Not Applicable

Comparison of the Analgesic Effect of Subsartorial Saphenous Block and Popliteal Sciatic vs Subsartorial Saphenous Block and IPACK in Total Knee Replacement Surgery. A Double Blind Randomized Clinical Trial.

Germans Trias i Pujol Hospital1 site in 1 country62 target enrollmentJune 10, 2020

Overview

Phase
Not Applicable
Intervention
IPACK block with Bupivacaine 0.25% with adrenaline
Conditions
Pain, Acute
Sponsor
Germans Trias i Pujol Hospital
Enrollment
62
Locations
1
Primary Endpoint
Pain at rest
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Total knee replacement surgery is associated with significant pain in the immediate postoperative period, especially in movement. In turn, this is associated with more subsequent chronic pain.

There are multiple options and the tendency is to perform increasingly distal nerve blocks to minimize limb weakness and thus allow early rehabilitation. In 2012, in an oral communication, Sanjay Sinha described a new nerve block called iPACK ("Interspace between the Popliteal Artery and the Capsule of the posterior Knee"). There are few studies on the efficacy of such a blockade so far, but none comparing the groups saphene + sciatic blocks vs. saphene + iPACK blocks.

Therefore, this study aims to provide more information on the effectiveness this nerve blocks, in total knee replacement, in terms of analgesia and motor function.

Registry
clinicaltrials.gov
Start Date
June 10, 2020
End Date
August 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dinu

Principal Investigator

Germans Trias i Pujol Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with osteoarthritis scheduled for total primary knee arthroplasty with same surgeons
  • Locoregional anesthesia
  • Age equal to or greater than 18 years
  • Consent to participate in the study

Exclusion Criteria

  • Age under 18 years old
  • General anesthesia
  • Allergy to local anesthetics
  • Severe kidney failure (Cr ≥ 2mg / dL)
  • Chronic opioid use (over 3 months)
  • Chronic pregabalin / gabapentin use (more than 3 months)
  • Psychiatric illness that may interfere with the evaluation or follow-up

Arms & Interventions

Echo-guided IPACK block

IPACK block using 0.25% bupivacaine 15mL with adrenaline once.

Intervention: IPACK block with Bupivacaine 0.25% with adrenaline

Echo-guided sciatic block

Sciatic nerve block using 0.25% bupivacaine 15mL with adrenaline once.

Intervention: IPACK block with Bupivacaine 0.25% with adrenaline

Outcomes

Primary Outcomes

Pain at rest

Time Frame: 48 hours after surgery

Measured by the numerical visual scale at 48 hours after intradural anesthesia, minimum of 0 and maximum of 10, where means no pain and 10 means the worst pain in the life of the patient.

Pain at movement

Time Frame: 6 hours after surgery

Measured by the numerical visual scale at 48 hours after intradural anesthesia, minimum of 0 and maximum of 10, where means no pain and 10 means the worst pain in the life of the patient.

Pain with movement

Time Frame: 48 hours after surgery

Measured by the numerical visual scale at 48 hours after intradural anesthesia, minimum of 0 and maximum of 10, where means no pain and 10 means the worst pain in the life of the patient.

Motor block

Time Frame: 48 hours after surgery

Measured on a scale of 3, where 0 = no motor block, 1 = partial motor block and 2 = complete motor block. It will be performed on plantar flexion (distribution of the tibial nerve) and dorsiflexion (peroneal distribution)).

Secondary Outcomes

  • Discharge days(Days)
  • Ambulation time(Up to 24 hours)
  • Opioids dose(48 hours after surgery)
  • Patient satisfaction(24 hours after surgery)

Study Sites (1)

Loading locations...

Similar Trials